Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
The Journal of Biological Chemistry
|
June 19, 2019
The steroid side-chain-cleaving aldolase Ltp2-ChsH2<sub>DUF35</sub> is a thiolase superfamily member with a radically repurposed active site
Rebecca Aggett, Evan Mallette, Stephanie E Gilbert, et al.
The Journal of Biological Chemistry
|
August 23, 2021
Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1
Yusong Guo, Qi Liu, Evan Mallette, et al.
Nature Chemical Biology
|
March 11, 2020
A bifunctional O-antigen polymerase structure reveals a new glycosyltransferase family
Bradley R Clarke, Olga G Ovchinnikova, Ryan P Sweeney, et al.
Protein Science : a Publication of the Protein Society
|
May 25, 2026
Dual targeting of inhibitory EGFR epitopes with synthetic antibodies in therapeutic-resistant cancers
Jarrett J Adams, Evan Mallette, Max London, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
The Journal of Biological Chemistry
|
June 19, 2019
The steroid side-chain-cleaving aldolase Ltp2-ChsH2<sub>DUF35</sub> is a thiolase superfamily member with a radically repurposed active site
Rebecca Aggett, Evan Mallette, Stephanie E Gilbert, et al.
The Journal of Biological Chemistry
|
August 23, 2021
Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1
Yusong Guo, Qi Liu, Evan Mallette, et al.
Nature Chemical Biology
|
March 11, 2020
A bifunctional O-antigen polymerase structure reveals a new glycosyltransferase family
Bradley R Clarke, Olga G Ovchinnikova, Ryan P Sweeney, et al.
Protein Science : a Publication of the Protein Society
|
May 25, 2026
Dual targeting of inhibitory EGFR epitopes with synthetic antibodies in therapeutic-resistant cancers
Jarrett J Adams, Evan Mallette, Max London, et al.
Page
of 2